Andre Lamy - McMaster Experts

Dr. Andre Lamy

Claim this profile

Hamilton General Hospital

Studies Coronary Artery Disease
Studies Heart Disease
5 reported clinical trials
8 drugs studied

Affiliated Hospitals

Image of trial facility.
Hamilton General Hospital
Image of trial facility.
Hamilton Health Sciences Corporation

Clinical Trials Andre Lamy is currently running

Image of trial facility.

Single vs Multiple Arterial Grafts

for Heart Disease

The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grfating (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and cerebrovascular events in women undergoing coronary artery bypass grfating (CABG). The investigators will compare major adverse cardiac and cerebrovascular events (death, stroke, non-procedural myocardial infarction, repeat revascularization, and hospital readmission for acute coronary syndrome or heart failure) in a cohort of 2,000 women randomized 1:1 to MAG or SAG (690 from the parent ROMA trial + 1,310 from ROMA:Women). Differences by important clinical and surgical subgroups (patients younger or older than 70 years, diabetics, racial and ethnic minorities, on vs off pump CABG, type of arterial grafts used) will also be evaluated. The women enrolled in the ongoing ROMA trial (anticipated to be approximately 690) will be included in ROMA:Women, increasing efficiency and reducing enrollment time. Hypothesis 1.0. MAG will reduce the incidence of major adverse cardiac and cerebrovascular events. Hypothesis 1.1. The improvement with MAG will be consistent across key subgroups. Aim 2: Determine the impact of MAG vs SAG on generic and disease-specific QOL, physical and mental health symptoms in women undergoing CABG. The investigators will compare generic (SF-12, EQ-5D) and disease-specific (Seattle Angina Questionnaire) QOL and physical and mental health symptoms (PROMIS-29) in a sub-cohort of 500 women randomized 1:1 to MAG or SAG (including those enrolled in ROMA:QOL). Differences by important subgroups (as defined above) will also be evaluated. Hypothesis 2.0. MAG will improve generic and disease-specific QOL compared to SAG. Hypothesis 2.1. MAG will improve physical and mental health symptoms compared to SAG. Hypothesis 2.2. The improvement with MAG will be consistent across key subgroups.
Recruiting1 award N/A4 criteria

More about Andre Lamy

Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Andre Lamy has experience with
  • Tranexamic Acid
  • Multiple Arterial Grafting
  • Single Arterial Graft
  • RBT-1
  • Multiple Arterial Grafting
  • Single Arterial Graft

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andre Lamy specialize in?
Andre Lamy focuses on Coronary Artery Disease and Heart Disease. In particular, much of their work with Coronary Artery Disease has involved treating patients, or patients who are undergoing treatment.
Is Andre Lamy currently recruiting for clinical trials?
Yes, Andre Lamy is currently recruiting for 1 clinical trial in Hamilton Ontario. If you're interested in participating, you should apply.
Are there any treatments that Andre Lamy has studied deeply?
Yes, Andre Lamy has studied treatments such as Tranexamic Acid, Multiple Arterial Grafting, Single Arterial Graft.
What is the best way to schedule an appointment with Andre Lamy?
Apply for one of the trials that Andre Lamy is conducting.
What is the office address of Andre Lamy?
The office of Andre Lamy is located at: Hamilton General Hospital, Hamilton, Ontario L8L 2X2 Canada. This is the address for their practice at the Hamilton General Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.